Ariel E. Feldstein
Impact in
- Epidemiology top 0.02%
- Liver Disease Diagnosis and Treatment
- Adipokines, Inflammation, and Metabolic Diseases
- Hepatology top 0.2%
- Liver physiology and pathology
Papers in
- Epidemiology 151
- Liver Disease Diagnosis and Treatment 142
- Adipokines, Inflammation, and Metabolic Diseases 7
- Hepatology 40
- Liver physiology and pathology 26
- Liver Diseases and Immunity 9
- Co-authors
- Paul Angulo (14 shared papers)Rocio Lopez (44 shared papers)Ali E. Canbay (15 shared papers)Naim Alkhouri (45 shared papers)Keith D. Lindor (7 shared papers)Alexander Wree (29 shared papers)Leon Anton Adams (5 shared papers)Akiko Eguchi (30 shared papers)
- Journals
- Hepatology (27 papers)Journal of Hepatology (15 papers)The American Journal of Gastroenterology (14 papers)Gastroenterology (12 papers)Digestive Diseases and Sciences (8 papers)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
Ariel E. Feldstein
223 papers receiving 29k citations
Ariel E. Feldstein's Hit Papers
Peers
Comparison fields: 5 of 145
- Epidemiology 15.1k
- Hepatology 3.2k
- Molecular Biology 7.4k
- Pharmacology 778
- Nutrition and Dietetics 763
Countries citing papers authored by Ariel E. Feldstein
This map shows the geographic impact of Ariel E. Feldstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariel E. Feldstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariel E. Feldstein more than expected).
Fields of papers citing papers by Ariel E. Feldstein
This network shows the impact of papers produced by Ariel E. Feldstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariel E. Feldstein. The network helps show where Ariel E. Feldstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Ariel E. Feldstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 229 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease Hit paper breakdown → | 2011 | 4627 |
| 2 | The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study Hit paper breakdown → | 2005 | 2462 |
| 3 | NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice Hit paper breakdown → | 2017 | 936 |
| 4 | Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis Hit paper breakdown → | 2003 | 928 |
| 5 | NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice Hit paper breakdown → | 2013 | 833 |
| 6 | Triggering and resolution of inflammation in NASH Hit paper breakdown → | 2018 | 764 |
| 7 | Free fatty acids promote hepatic lipotoxicity by stimulating TNF-α expression via a lysosomal pathway Hit paper breakdown → | 2004 | 693 |
| 8 | The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years Hit paper breakdown → | 2009 | 631 |
| 9 | Cytokeratin-18 Fragment Levels as Noninvasive Biomarkers for Nonalcoholic Steatohepatitis Hit paper breakdown → | 2009 | 589 |
| 10 | In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease Hit paper breakdown → | 2006 | 566 |
| 11 | From NAFLD to NASH to cirrhosis—new insights into disease mechanisms Hit paper breakdown → | 2013 | 527 |
| 12 | Increased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic Steatohepatitis Hit paper breakdown → | 2008 | 520 |
| 13 | NLRP3 inflammasome activation is required for fibrosis development in NAFLD Hit paper breakdown → | 2014 | 431 |
| 14 | Innate Immunity and Inflammation in NAFLD/NASH Hit paper breakdown → | 2016 | 413 |
| 15 | 2007 | 367 | |
| 16 | 2009 | 351 | |
| 17 | 2009 | 336 | |
| 18 | 2009 | 322 | |
| 19 | 2010 | 320 | |
| 20 | 2011 | 306 |
About Ariel E. Feldstein
Ariel E. Feldstein is a scholar working on Epidemiology, Hepatology, Molecular Biology, Pathology and Forensic Medicine and Nutrition and Dietetics, having authored 229 papers that have together received 29.7k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (142 papers), Liver physiology and pathology (26 papers), Inflammasome and immune disorders (16 papers), Extracellular vesicles in disease (14 papers), Alcohol Consumption and Health Effects (10 papers), Liver Diseases and Immunity (9 papers), Adipokines, Inflammation, and Metabolic Diseases (7 papers) and Cell death mechanisms and regulation (7 papers). The work is most often cited by research in Epidemiology (15.1k citations), Hepatology (3.2k citations), Molecular Biology (7.4k citations), Pharmacology (778 citations) and Nutrition and Dietetics (763 citations). Ariel E. Feldstein has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Paul Angulo, Rocio Lopez, Ali E. Canbay, Naim Alkhouri, Keith D. Lindor, Alexander Wree, Leon Anton Adams, Akiko Eguchi, Nizar N. Zein and Gregory James Gores. Their work appears in journals such as Hepatology, Journal of Hepatology, The American Journal of Gastroenterology, Gastroenterology and Digestive Diseases and Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.